Publication: 2997

Publication: 2997

Oral Azacitidine (CC-486) Plus R-CHOP in Patients With High-Risk or Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma (AFT-08)

DOI

URL

Google Scholar

Citation:: Blood vol 132 (Suppl 1) 2964

Meeting Instance:: ASH 2018
Year:: 2018
Type:: Abstract
Sub type:: Poster Discussion
Funding:: AFT
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3481

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Celgene
Grants:

Corr. Author:
Authors:: Peter Martin Nancy L. Bartlett Julio C. Chavez John L. Reagan Sonali M. Smith Ann LaCasce Maria Revuelta Jeffrey Jones James Drew Chengqing Wu Leandro Cerchietti John P. Leonard

Networks:: FL310, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, NEWMEXICO, NY018, RI005, TX041

Study: AFT-08
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: